Form 4 holding
Chief Development Officer
Immunovant, Inc.
- Security class
- Common Stock
- Shares / value
- 440,959
- Estimated value
- $14,251,795
- Report date
- 21 Aug 2024
- Price
- $32.32
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|